5:58 PM Mar 16, 2018

Progressing platforms

Mark McClellan, director of the Duke-Margolis Center for Health Policy, is hopeful that attendees of the group’s March 19 meeting on novel statistical methods and trial designs will walk out...

3:19 PM Mar 16, 2018

Hong Kong’s new chapter

Introducing a biotech chapter to the Hong Kong stock exchange fills a massive void in the region’s innovation ecosystem, but won’t come without risks.

11:54 AM Mar 15, 2018

Engineered to kill

Nkarta Inc. is betting that boosting NK cells’ intrinsic ability to discriminate between cancer and healthy cells will increase their efficacy as anti-cancer agents and lower their risk of...

11:52 AM Mar 15, 2018

Shared burden

Having learned their lesson with PD-L1, companies are collaborating on assay standards for tumor mutation burden -- a likely contender for the next major biomarker in immuno-oncology. A Friends of...

6:44 PM Mar 09, 2018

Virtual leap

Novartis AG’s decision to expand a collaboration with mobile technology and clinical trials management company Science 37 Inc. fits squarely within CEO Vasant Narasimhan’s oft-stated plans to...


Latest News

4:49 PM Mar 16, 2018

New Cas enzyme can edit RNA, target tau

In Cell, researchers from the Salk Institute for Biological Studies discovered a new RNA-targeting CRISPR...

4:24 PM Mar 16, 2018

CMS issues final coverage decision for NGS cancer tests

CMS issued a final National Coverage Determination (NCD) on Friday for next-generation sequencing (NGS)...

4:11 PM Mar 16, 2018

Management tracks: America's Health Insurance Plans, Astellas

Health insurance trade association America's Health Insurance Plans (AHIP) said President and CEO Marilyn...

3:40 PM Mar 16, 2018

PTAB: Orange Book patents survive best among tech IPRs

The U.S. Patent and Trademark Office's Patent Trial and Appeal Board found that more than half of Orange...

2:21 PM Mar 16, 2018

House committee to discuss right-to-try bill

The House Rules Committee will meet on March 19 to consider a right-to-try bill, setting the stage for a...

1:58 PM Mar 16, 2018

CSL's Hizentra gains approvals for rare disease CIDP

CSL Ltd. (ASX:CSL) subsidiary CSL Behring said FDA and the European Commission have each approved Hizentra...

1:24 PM Mar 16, 2018

ICER draft: Some Vertex CF drug prices should be halved

The Institute for Clinical and Economic Review said the prices of two of three cystic fibrosis drugs from...

3:47 AM Mar 16, 2018

Lundbeck snags PD play Prexton

H. Lundbeck A/S (CSE:LUN) will acquire Prexton Therapeutics B.V. (Oss, the Netherlands) for €100...

6:29 PM Mar 15, 2018

Ionis looks to Akcea for speedy launch of inotersen

With an eye toward a commercialization race in hereditary transthyretin (TTR) amyloidosis (hATTR), Ionis...

4:53 PM Mar 15, 2018

Alexion's long-acting C5 inhibitor meets in Phase III

Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) said Thursday that ALXN1210, its long-acting formulation of...

3:06 PM Mar 15, 2018

Imaging tool may optimize CAR T therapy for solid tumors

Researchers from King's College London and colleagues developed a real-time imaging technology to track...

2:19 PM Mar 15, 2018

FDA panel to review Lilly's Olumiant

FDA's Arthritis Advisory Committee will meet on April 23 to discuss an NDA for Olumiant baricitinib from...

2:03 PM Mar 15, 2018

Adaptimmune gains on early liposarcoma data for NY-ESO SPEAR T cells

Adaptimmune Therapeutics plc (NASDAQ:ADAP) gained $1.73 (19%) to $10.94 on Thursday after reporting that...

1:22 PM Mar 15, 2018

Adapting T cell manufacturing methods could improve CAR Ts

Researchers at The Children's Hospital of Philadelphia identified key factors that affect the potential of...

12:13 PM Mar 15, 2018

Solid tumbles after clinical hold

Solid Biosciences Inc. (NASDAQ:SLDB) sank $16.99 (65%) to $9.32 on Thursday, shedding about $600 million...

12:02 PM Mar 15, 2018

Supernus raises $350M in convertible senior notes

Neurology company Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) raised $350 million through the sale of 0....

11:57 AM Mar 15, 2018

La Jolla prices $100.3M follow-on

La Jolla Pharmaceutical Co. (NASDAQ:LJPC) raised $100.3 million through the sale of 3.4 million shares at $...

10:49 AM Mar 15, 2018

Modest first-day pop for Arcus after upsized $120M IPO

Arcus Biosciences Inc. (NYSE:RCUS) climbed $2.08 (14%) to $17.08 on Thursday after raising $120 million...

9:03 AM Mar 15, 2018

Arbor launches with $15.6 million, new CRISPR enzyme

Arbor Biotechnologies Inc. (Cambridge, Mass.) emerged from stealth mode on Thursday with a study detailing...

4:55 AM Mar 15, 2018

Synthetic lethality company Ideaya raises $94M

Ideaya Biosciences Inc. (South San Francisco, Calif.) raised $94 million in a series B round led by...

Down Up